CARL · CARLSMED INC
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Market Cap
403.5M
52 Wk Range
$8.50 - $17.23
Previous Close
$14.78
Open
$14.87
Volume
48,406
Day Range
$14.43 - $15.00
Enterprise Value
336.2M
Cash
89.22M
Avg Qtr Burn
-7.358M
Insider Ownership
45.04%
Institutional Own.
40.44%
Qtr Updated
Jun 30th 2026
